Analysis of suscebility genes and pathogenesis of HTLV-I-associated Sjogren's syndrome

HTLV-I相关干燥综合征易感基因及发病机制分析

基本信息

项目摘要

HTLV-I has been identified as a causative agent which initiates and/or perpetuates the process of Sjogren's syndrome (SS). A high seroprevalence of HTLV-I infection has been determined in SS patients in the HTLV I-endemic area of Nagasaki, Japan. Many patients with HTLV-I-associated myelopathy (HAM/TSP) have been complicated with SS. The present study was undertaken to clarify the involvement of HTLV-I infection on the development or perpetuation of SS. At first, we analyzed promoter region polymorphisms of the IL-10 gene. Our results suggest that the presence of the ATA haplotype of the IL-10 gene are associated with an increased susceptibility to primary SS. Moreover, IL-10 gene promoter region polymorphism affects the age at onset of SS, and the amounts of serum IgG. However, there is no association between the presence of anti-HTLV-I antibodies and IL-10 gene polymorphism. Next, two-color analysis by flow cytometry revealed a significantly high percentage of IL-12Rβl^+ cells in CD4 … More ^+T lymphocytes in HAM/TSP patients compared to the control. These results suggest Th1 immune activation in patients with HAM/TSP, which leads to chronic inflammation in the tissues, mediated by dysregulation of the IL-12/IL-12R. Furthermore, the sLe^<x+>+ cell population, which has features of activated Th1 cells with up-regulated expression of E-selectin and P-selectin ligands mediated by HTLV I infection, is increased in peripheral blood CD4^+T lymphocytes in HAM/TSP patients. These findings suggest their involvement in transmigration of T lymphocytes from peripheral blood into tissues. In addition, our results indicate that peripheral blood CD4^+T lymphocytes of HAM/TSP patients are resistant to apoptosis triggered through mitochondrial death pathway through up-regulations of expression of anti-apoptotic protein, Bcl-xL. We used HTLV-I tax transfectants to show that tax-mediated induction of Bcl-xL expression can protect cells from apoptotic stimuli in a mitochondria-dependent fashion. Compared with tax-negative JPX-9 cells, Bcl-xL expression was clearly augmented in tax-positive JPX-9 cells. These cells were resistant to both receptor-mediated apoptosis and chemical induced apoptosis. Theses results suggest that tax-mediated Bcl-xL expression inhibit apoptosis of activated T lymphocytes in HTLV-I-seropositive subjects, which consequently promotes the onset of autoimmune disorders such as SS. Finally, we demonstrated the expression of TLR-2, TLR-3 and TLR4 on the acinal and ductal cells, and infiltrated mononuclear cells from minor salivary glands of SS. When a human salivary glands (HSG) cell line were stimulated by peptidoglycan, poly I : C, or LPS, HSG cell line augmented the expression of CD54 and production of IL-6, through the phosphorylation of MAP kinase. From the above findings, the development and/or perpetuation of SS might be implicated with HTLV-I infection and the susceptibility genes. Less
HTLV-I已被确定为一种因果剂,它启动和/或永久化了Sjogren综合征(SS)的过程。在日本长崎的HTLV I-末端区域的SS患者中,已经确定了HTLV-1感染的高血清阳性感染。许多患有HTLV-I相关性骨髓病(HAM/TSP)的患者与SS复杂。本研究的目的是阐明HTLV-I感染有关SS的发展或永久性的参与。首先,我们分析了IL-10基因的启动子区域多态性。我们的结果表明,IL-10基因的ATA单倍型的存在与对原代SS的敏感性增加有关。此外,IL-10基因启动子区域多态性会影响SS发作时的年龄和血清IgG的量。但是,抗HTLV-I抗体的存在与IL-10基因多态性之间没有关联。接下来,通过流式细胞仪进行两种彩色分析显示,与对照相比,HAM/TSP患者中CD4中的IL-12RβL ^+细胞的比例明显很高。这些结果表明,HAM/TSP患者的Th1免疫激活,这会导致组织中的慢性炎症,这是由IL-12/IL-12R失调介导的。此外,在HAM/TSP患者中,在外周血CD4^+T淋巴细胞中增加了活性Th1细胞的SLE^<X+>+细胞群,其具有上调的E-选择蛋白和P-选择蛋白配体的表达的特征增加。这些发现表明它们参与了T淋巴细胞从外周血传播到组织中。此外,我们的结果表明,HAM/TSP患者的外周血CD4^+T淋巴细胞对通过线粒体死亡途径触发的凋亡具有抗性,这是通过对抗凋亡蛋白表达的上调BCl-XL的表达。我们使用HTLV-I税收转换物来表明,税收介导的BCl-XL表达可以以线粒体依赖性方式保护细胞免受凋亡刺激。与税收阴性JPX-9细胞相比,在税阳性JPX-9细胞中明显增强了BCL-XL表达。这些细胞对受体介导的凋亡和化学诱导的凋亡均具有抗性。这些结果表明,税收介导的BCL-XL表达抑制了HTLV-I - 膜阳离子受试者中活化T淋巴细胞的凋亡,从而促进了SS自身免疫性疾病(如SS)的发作。最后,我们证明了TLR-2,TLR-3和TLR4在刺激细胞和导管细胞上的表达,以及来自SS的次要唾液腺的浸润的单核细胞。当人类唾液腺(HSG)细胞系被辣椒,Poly I:C或LPS刺激时,HSG细胞系通过MAP激酶的磷酸化增强了CD54的表达和IL-6的产生。从上面的发现中,SS的发展和/或永久性可能与HTLV-I感染和易感基因有关。较少的

项目成果

期刊论文数量(359)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Ida H: "Granzyme B leakage-induced cell death: a new type of activation -induced natural killer cell death"J Immunol. (accepted).
Ida H:“颗粒酶 B 渗漏诱导的细胞死亡:一种新型的激活诱导的自然杀伤细胞死亡”J Nutrition。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Kawakami A: "Modulation of the expression of membrance-bound CD54(mCD54) and soluble from of CD54(sCD54) in endothelial cells by glucosyl transferase inhibitor;"Biochem Biophys Res Commun. 296・1. 26-31 (2002)
Kawakami A:“通过葡萄糖基转移酶抑制剂调节内皮细胞中膜结合CD54(mCD54)和可溶性CD54(sCD54)的表达”;Biochem Biophys Res Commun.296·1。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Yamasaki S.: "Importance of NF-kB in rheumatoid synovial tissues : in situ NF-κB expression and in vitro study using cultured synovial cells"Ann Rheum Dis. 60(7). 678-684 (2001)
Yamasaki S.:“NF-kB 在类风湿滑膜组织中的重要性:原位 NF-kB 表达和使用培养滑膜细胞的体外研究”Ann Rheum Dis. 60(7)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Yanagi K: "Immuno-gene therapy with adenoviruses expressing fms-like tyrosine kinase 3 ligand and CD40 ligand for mouse hepatoma cells in vivo"Int J Oncol. 22. 345-351 (2003)
Yanagi K:“用表达 fms 样酪氨酸激酶 3 配体和 CD40 配体的腺病毒对体内小鼠肝癌细胞进行免疫基因治疗”Int J Oncol。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Origuchi T, et al.: "Correlation between interleukm 10 gene promoter region polymorphisms and clinical manifestations in Japanese patients with Sjogren's syndrome."Ann Rheum Dis. 62(11). 1117-1118 (2003)
Origuchi T 等人:“白介素 10 基因启动子区域多态性与日本干燥综合征患者临床表现的相关性。”Ann Rheum Dis。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
共 155 条
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 31
前往

EGUCHI Katsumi的其他基金

Role of innate immunity on initiation of autoimmune diseases and its regulation
先天免疫在自身免疫性疾病发生中的作用及其调控
  • 批准号:
    15390316
    15390316
  • 财政年份:
    2003
  • 资助金额:
    $ 6.46万
    $ 6.46万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
    Grant-in-Aid for Scientific Research (B)
Mechanisms of immunoregulation by serine proteinase inhibitor and its application of therapy for rheumatic disease
丝氨酸蛋白酶抑制剂的免疫调节机制及其在风湿病治疗中的应用
  • 批准号:
    13670461
    13670461
  • 财政年份:
    2001
  • 资助金额:
    $ 6.46万
    $ 6.46万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
    Grant-in-Aid for Scientific Research (C)
Role of Fas mediated apoptosis in the process of autoimmune thyroid diseases : possible involvement of Fas ligand (FasL) expression in breakdown of "immunoprevileged site" formation
Fas 介导的细胞凋亡在自身免疫性甲状腺疾病过程中的作用:Fas 配体 (FasL) 表达可能参与“免疫抑制位点”形成的破坏
  • 批准号:
    11671091
    11671091
  • 财政年份:
    1999
  • 资助金额:
    $ 6.46万
    $ 6.46万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
    Grant-in-Aid for Scientific Research (C)
Role of HTLV-I on pathegenesis of Sjogren's syndrome
HTLV-I 在干燥综合征发病机制中的作用
  • 批准号:
    09670482
    09670482
  • 财政年份:
    1997
  • 资助金额:
    $ 6.46万
    $ 6.46万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
    Grant-in-Aid for Scientific Research (C)
ROLE OF HUMAN T LYMPHOTROPIC VIRUS TYPE I ON PATHOGENESIS OF SJOGREN'S SYNDROME
I型人类T淋巴细胞病毒在干燥综合征发病机制中的作用
  • 批准号:
    07670534
    07670534
  • 财政年份:
    1995
  • 资助金额:
    $ 6.46万
    $ 6.46万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
    Grant-in-Aid for Scientific Research (C)
Role of adult T cell lymphotropic virus 1 on pathogenesis of Sjogren's syndrome.
成人 T 细胞嗜淋巴细胞病毒 1 在干燥综合征发病机制中的作用。
  • 批准号:
    05670426
    05670426
  • 财政年份:
    1993
  • 资助金额:
    $ 6.46万
    $ 6.46万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
    Grant-in-Aid for General Scientific Research (C)
Role of HTLV-I infection in development of chronic inflammatory arthropathy.
HTLV-I 感染在慢性炎症性关节病发展中的作用。
  • 批准号:
    02670285
    02670285
  • 财政年份:
    1990
  • 资助金额:
    $ 6.46万
    $ 6.46万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
    Grant-in-Aid for General Scientific Research (C)

相似国自然基金

TRIM24调控巨噬细胞IL-10在LPS诱导的ALI/ARDS中的作用和机制研究
  • 批准号:
    82360317
  • 批准年份:
    2023
  • 资助金额:
    32 万元
  • 项目类别:
    地区科学基金项目
IL-10基因启动子区GAGTT插入/缺失变异影响草鱼出血病抗性的作用机理
  • 批准号:
    32302993
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
CTCFL调控IL-10抑制CD4+CTL旁观者激活促口腔鳞状细胞癌新辅助免疫治疗抵抗机制研究
  • 批准号:
    82373325
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
ATF3促进腹腔B1a细胞分泌IL-10参与原发性胆汁性胆管炎的作用探究
  • 批准号:
    82300579
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
低氧响应性IL-10活菌药物泡沫剂的构建及其在炎症性肠病治疗中的应用
  • 批准号:
    32301125
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

The IL20 Genetic Polymorphism Is Associated with Altered Clinical Outcome in Septic Shock.
IL20 基因多态性与感染性休克临床结果的改变相关。
  • 批准号:
    15H02568
    15H02568
  • 财政年份:
    2015
  • 资助金额:
    $ 6.46万
    $ 6.46万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
    Grant-in-Aid for Scientific Research (A)
The use of genetically humanized IL-10 mice to determine the molecular basis of a
使用基因人源化 IL-10 小鼠来确定 IL-10 的分子基础
  • 批准号:
    8776126
    8776126
  • 财政年份:
    2014
  • 资助金额:
    $ 6.46万
    $ 6.46万
  • 项目类别:
Role of microRNAs in modulating inflammation in alpha-syn mediated models of PD
microRNA 在调节 α-syn 介导的 PD 模型炎症中的作用
  • 批准号:
    9015787
    9015787
  • 财政年份:
    2014
  • 资助金额:
    $ 6.46万
    $ 6.46万
  • 项目类别:
The use of genetically humanized IL-10 mice to determine the molecular basis of allele-specific gene expression and disease susceptibility
使用基因人源化 IL-10 小鼠确定等位基因特异性基因表达和疾病易感性的分子基础
  • 批准号:
    9278093
    9278093
  • 财政年份:
    2014
  • 资助金额:
    $ 6.46万
    $ 6.46万
  • 项目类别:
PARP-1 in Juvenile Idiopathic Arthritis-associated IL-10 Promoter Polymorphisms
PARP-1 与幼年特发性关节炎相关的 IL-10 启动子多态性
  • 批准号:
    7911718
    7911718
  • 财政年份:
    2009
  • 资助金额:
    $ 6.46万
    $ 6.46万
  • 项目类别: